España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BrainsWay
BWAY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.87
-0.36
-3.52%
Pre-Market: Jan 16, 5:26 PM EDT
Get Report
Comment
BrainsWay (BWAY) Forecast
News
Earnings
BrainsWay (BWAY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BrainsWay (NASDAQ:BWAY) Stock
BrainsWay Stock (NASDAQ: BWAY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 23, 2024
HC Wainwright & Co. Reiterates Buy on BrainsW...
Benzinga Newsdesk
Thursday, December 12, 2024
BrainsWay Reports Independent Pilot Data On A...
Benzinga Newsdesk
Wednesday, November 20, 2024
BrainsWay Announces The Publication Of Feasib...
Benzinga Newsdesk
Tuesday, November 12, 2024
BrainsWay Q3 2024 GAAP EPS $0.02 Beats $0.01 ...
Benzinga Newsdesk
BrainsWay Raises FY2024 Sales Guidance to $40...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, October 21, 2024
HC Wainwright & Co. Reiterates Buy on BrainsW...
Benzinga Newsdesk
Tuesday, October 15, 2024
Are Medical Stocks Lagging Brainsway This Year?
Zacks
Wednesday, October 09, 2024
BrainsWay Announced The Further Expansion Of ...
Benzinga Newsdesk
Thursday, October 03, 2024
Northland Capital Markets Maintains Outperfor...
Benzinga Newsdesk
Monday, September 30, 2024
What's Going On With BrainsWay Shares Monday?
Dylan Berman
BrainsWay shares are trading higher after the...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
BrainsWay Secures $20M Investment from Valor ...
Benzinga Newsdesk
Monday, September 16, 2024
HC Wainwright & Co. Reiterates Buy on BrainsW...
Benzinga Newsdesk
BrainsWay Announced The Expansion Of Its Deep...
Benzinga Newsdesk
Friday, August 09, 2024
Why Brainsway Might be Well Poised for a Surge
Zacks
Thursday, August 08, 2024
HC Wainwright & Co. Maintains Buy on BrainsWa...
Benzinga Newsdesk
Wednesday, August 07, 2024
Northland Capital Markets Maintains Outperfor...
Benzinga Newsdesk
Tuesday, August 06, 2024
BrainsWay Raises Lower End Of FY24 Revenue Gu...
Benzinga Newsdesk
BrainsWay Q2 GAAP EPS $0.04 Up From $(0.10) Y...
Benzinga Newsdesk
Monday, July 22, 2024
Brainsway Files For Mixed Shelf Of Up To $100...
Benzinga Newsdesk
Wednesday, June 19, 2024
BrainsWay Inks Distribution Agreement to Expand Foothold
Zacks
Monday, June 17, 2024
BrainsWay Secures Exclusive Multi-Year Distri...
Benzinga Newsdesk
Monday, June 10, 2024
BrainsWay Initiates Prospective, Randomized, ...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on BrainsW...
Benzinga Newsdesk
Monday, June 03, 2024
BrainsWay Says FDA Has Granted Expanded Indic...
Benzinga Newsdesk
Thursday, May 09, 2024
Oppenheimer Maintains Outperform on BrainsWay...
Benzinga Newsdesk
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on BrainsWa...
Benzinga Newsdesk
Wednesday, May 08, 2024
BrainsWay Reiterates FY24 Revenue Guidance Of...
Benzinga Newsdesk
BrainsWay Q1 Sales $9.095M Beat $8.720M Estim...
Benzinga Newsdesk
Wednesday, April 17, 2024
BrainsWay Expands Deep TMS Access In Israel; ...
Benzinga Newsdesk
Thursday, April 04, 2024
BrainsWay Announces Published Review Results ...
Benzinga Newsdesk
Thursday, March 28, 2024
BrainsWay Announces Publication Of Results In...
Benzinga Newsdesk
Monday, March 18, 2024
BrainsWay's Existing Partner, Katie's Way Plu...
Benzinga Newsdesk
Monday, March 11, 2024
HC Wainwright & Co. Maintains Buy on BrainsWa...
Benzinga Newsdesk
Wednesday, March 06, 2024
BrainsWay Q4 Earnings Per ADS $0.00 Beats $(0...
Benzinga Newsdesk
BrainsWay Provides Full-Year 2024 Revenue Gui...
Benzinga Newsdesk
BrainsWay Q4 Sales $9.03M Beat $8.42M Estimat...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights
Tuesday, March 05, 2024
BrainsWay Earnings Preview
Benzinga Insights
Wednesday, January 10, 2024
BrainsWay Announced That It Will Be Clinicall...
Benzinga Newsdesk
Monday, January 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, December 07, 2023
BrainsWay Announced Expanded Availability Of ...
Benzinga Newsdesk
Monday, November 20, 2023
BrainsWay Announced That Blue Cross Blue Shie...
Benzinga Newsdesk
Thursday, November 16, 2023
5 Analysts Have This to Say About BrainsWay
Benzinga Insights
Oppenheimer Maintains Outperform on BrainsWay...
Benzinga Newsdesk
Raymond James Downgrades BrainsWay to Market ...
Benzinga Newsdesk
Wednesday, November 15, 2023
BrainsWay shares are trading higher after the...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
